Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline.

Joanne RyanElsdon StoreyAnne M MurrayRobyn L WoodsRory WolfeChristopher M ReidMark R NelsonTrevor T J ChongJeff D WilliamsonStephanie A WardJessica E LockerySuzanne G OrchardRuth TrevaksBrenda KirpachAnne B NewmanMichael E ErnstJohn J McNeilRaj C Shahnull null

Published in: Neurology (2020)

NCT01038583.

Keyphrases

cognitive decline
mild cognitive impairment
double blind
placebo controlled
clinical trial
low dose
phase iii
open label
cardiovascular events
antiplatelet therapy
phase ii
study protocol
cognitive impairment
percutaneous coronary intervention
coronary artery disease
type diabetes